Docetaxel Anhydrous used mainly for the treatment of breast, ovarian, and non-small cell lung cancer. Docetaxel reversibly binds to tubulin with high affinity in a 1:1 stoichiometric ratio. It is a clinically well established anti-mitotic chemotherapy medication. Reference standards of Docetaxel Anhydrous API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
7,10-O-Bis{[(2,2,2,-trichloroethyl)oxy]carbonyl} Docetaxel-d9
Catalogue No.:PA STI 016620
CAS :
Molecular Formula : C49H46D9Cl6NO18
Molecular Weight : 1167.73
2-(1,1-Diethoxy-2-methyl)propyl 4'-Nitrophenyl Carbonate-d6
Catalogue No.:PA STI 031120
Molecular Formula : C15H15D6NO7
Molecular Weight : 333.37
Docetaxel-d6 Metabolites M1 and M3 (Mixture of Diastereomers)
Catalogue No.:PA STI 035940
Molecular Formula : C43H45D6NO15
Molecular Weight : 827.90
Docetaxel-d9
Catalogue No.:PA STI 035960
Molecular Formula : C43H44D9NO14
Molecular Weight : 816.93
Docetaxel-d5
Catalogue No.:PA STI 035970
Molecular Formula : C43H48D5NO14
Molecular Weight : 812.91
2-Desbenzoyl-2-tiglyl Docetaxel-d9
Catalogue No.:PA STI 035980
Molecular Formula : C41H46D9NO14
Molecular Weight : 794.93
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
